StockData
LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

LENSAR, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$5.75−0.05 (-0.86%)

Close on Oct 19, 2026

Market cap
$132.41M
P/E (TTM)
–
Dividend yield
–

LENSAR, Inc. revenue by segment

By business segment

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Product$13.04M$10.08M$12.73M$11.37M$10.91M$10.92M$13.52M$10.58M$9.53M$7.43M$9.45M$7.16M79.1%+19.5%
Service$1.68M$1.67M$1.60M$1.39M$1.38M$1.36M$1.30M$1.24M$1.15M$1.21M$1.05M$1.12M10.2%+21.8%

By region

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
United States$10.40M$8.53M$11.19M$8.67M$7.75M$6.70M$9.13M$6.09M$7.68M$6.01M$8.15M$5.74M63.0%+34.2%
Europe$2.31M$1.88M$1.46M$2.31M$2.41M$2.25M$3.53M$3.54M$1.67M$1.42M$1.13M$934.00K14.0%-4.3%
Asia$1.95M$1.26M––$2.05M$3.26M––––––11.8%-4.7%
Other$62.00K$67.00K$54.00K$41.00K$76.00K$67.00K$402.00K$63.00K$44.00K$54.00K$102.00K$481.00K0.4%-18.4%
Asia (Excluding South Korea)––$1.52M$1.55M$1.87M$3.08M$1.64M$1.98M$988.00K$884.00K$896.00K$1.10M––
South Korea––$106.00K$183.00K$181.00K$188.00K$121.00K$145.00K$304.00K$278.00K$223.00K$9.00K––

From the segment and revenue-disaggregation notes of Lensar's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.